Under the “strategic collaboration,” subsidiary DeepHealth and GE will develop solutions that harness AI to address key challenges in radiology. 

Pylarify is a PSMA-targeted PET agent for pinpointing suspected metastasis or recurrence of prostate cancer, which will be impacted by a new Medicare policy change.  

HATco, part of General Catalyst, is set to purchase the Ohio-based health system, which currently has roughly $850 million in debt on its balance sheet. 

Six multispecialty cardiovascular societies have called on CMS to approve Medicare payments for tricuspid transcatheter edge-to-edge repair (T-TEER).

Meanwhile, MRI and CT volumes both increased nearly 10% in Q3 when compared to the same period in 2023, the Los Angeles-based company reported.

However, an analysis from research firm PitchBook suggests a rebound could be on the horizon, as investors shift their gaze to specialty care services. 

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

Researchers with the University of California, Davis, detailed their randomized clinical trial in JAMA Network Open Wednesday.